Subjects: “...Cross infection...”
Access document

“... on functional respiratory capacity in elderly people after COVID-19. Methods – A cross-sectional study was...”
Access document

Subjects: “...Cross-linking reagents...”
Access document

“... were less inclined to decrease other sources of stress in their lives, to stay active, and to get...”
Access document

“... physical activity and quality of life of women during and after breast cancer treatment. Methods: Sample...”
Access document

“... (ER) rotators of the shoulder after Bristow/Latarjet surgery. Methods Cross-sectional study with 18 patients...”
Access document

Subjects: “...cross-fertilization...”
Access document

“... increase their reproductive success after the end of grouping; (b) the copulation behaviour and the...”
Access document (1)
Access document (2)

“... aimed to perceive potential cross-contamination events during preparation of raw poultry that can...”
Access document

“... aimed to perceive potential cross-contamination events during preparation of raw poultry that can...”
Access document

“... aimed to perceive potential cross-contamination events during preparation of raw poultry that can...”
Access document

“... thinning and steepening. Corneal collagen cross-linking (CXL) uses riboflavin and ultraviolet-A radiation...”
Access document

“... function of patients with and without nutritional risk. Methods: cross-sectional study conducted with...”
Access document

Subjects: “...Cross Infection...”
Access document

Subjects: “...Cross Infection...”
Access document

“...). During wave 1, C1 and C2 were associated with a decrease in deaths after 49-days and C3 after 21, 28 and...”
Access document

“.../sequelae on functional respiratory capacity in the elderly after CoViD-19. Methodology: A cross-sectional...”
Access document

Subjects: “...Cross-validation...”
Access document (1)
Access document (2)

“...The levels of adequacy of movement behaviors after returning to in-person school activities...”
Access document

“... of pyridostigmine (PYR), a reversible acetylcholinesterase inhibitor. METHODS: A double-blind, randomized, cross...”
Access document